Ivan Fan‐Ngai Hung

Active 2003–2025

Also published as
Ivan Fan-Ngai Hung · Ivan Fan Ngai Hung
187
Papers
28,838
Citations
77
h-index
182
i10-index

Citations

Citations per year for Ivan Fan‐Ngai Hung1978: 1 citations1980: 1 citations1989: 1 citations1991: 2 citations1998: 1 citations2001: 2 citations2003: 5 citations2004: 47 citations2005: 49 citations2006: 26 citations2007: 32 citations2008: 25 citations2009: 24 citations2010: 64 citations2011: 68 citations2012: 89 citations2013: 99 citations2014: 58 citations2015: 77 citations2016: 73 citations2017: 64 citations2018: 67 citations2019: 218 citations2020: 3,736 citations2021: 3,088 citations2022: 1,698 citations2023: 698 citations2024: 677 citations2025: 244 citations2026: 5 citations1979: no citations, so this year is not shown1981–1988: no citations, so these years are not shown1990: no citations, so this year is not shown1992–1997: no citations, so these years are not shown1999–2000: no citations, so these years are not shown2002: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,784 citing papers, 17.5% of this breakdownChina: 2,035 citing papers, 12.8% of this breakdownUnited Kingdom: 987 citing papers, 6.2% of this breakdownHong Kong: 772 citing papers, 4.9% of this breakdownItaly: 729 citing papers, 4.6% of this breakdownIndia: 644 citing papers, 4% of this breakdownCanada: 515 citing papers, 3.2% of this breakdownGermany: 476 citing papers, 3% of this breakdownFrance: 436 citing papers, 2.7% of this breakdownAustralia: 386 citing papers, 2.4% of this breakdownSpain: 372 citing papers, 2.3% of this breakdownBrazil: 345 citing papers, 2.2% of this breakdown
0%17.5%Other 34.2%

Fields

  • Medicine78.8%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Immunology and Microbiology3.1%
  • Dentistry2.3%
  • Mathematics2.3%
  • Computer Science1.4%
  • Other7.3%

Topics

  • SARS-CoV-2 and COVID-19 Research14.2%
  • COVID-19 Clinical Research Studies13.6%
  • SARS-CoV-2 detection and testing6.5%
  • Long-Term Effects of COVID-195.2%
  • COVID-19 diagnosis using AI2.9%
  • COVID-19 epidemiological studies2.4%
  • Other55.2%

Coauthors

All papers

Open in search
  1. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 cited by 1,700

  2. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 3,377

  3. Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic

    Authors: , , , , , , , , , , , - Emerging Microbes & Infections 2021 cited by 361

  4. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses

    Authors: , , , , , , , , , , , , , , , , , , - Immunity 2020 cited by 569

  5. Frequency and Distribution of Chest Radiographic Findings in Patients Positive for COVID-19

    Authors: , , , , , , , , , , , , , , , - Radiology 2020 cited by 1,524

  6. Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alwin Yeung, Tak-Chiu Wu, Johnny Wai-Man Chan, Wing-Wah Yan, Wai-Ming Chan, Jasper Fuk‐Woo Chan, Albert Kwok-Wai Lie, Owen Tak-Yin Tsang, Vincent Chi‐Chung Cheng, Tak-Lun Que, Chak-Sing Lau, Kwok‐Hung Chan, Kelvin Kai‐Wang To, Kwok-Yung Yuen - The Lancet 2020 cited by 1,567

  7. Consistent Detection of 2019 Novel Coronavirus in Saliva

    Authors: , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2020 cited by 1,996

  8. Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines

    Authors: , , , , , , , , , , , , , , , - Frontiers in Immunology 2019 cited by 181

  9. Global Consumption Trend of Antifungal Agents in Humans From 2008 to 2018: Data From 65 Middle- and High-Income Countries

    Authors: , , , , , , , , , - Drugs 2022 cited by 71

  10. Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kong‐Hung Sze, Jinxia Zhang, Hin Chu, Kin‐Hang Kok, Dong Wang, Xuehui Cai, Jeffrey D. Esko, Ivan Fan‐Ngai Hung, Ronald Adolphus Li, Honglin Chen, Hongzhe Sun, Dong‐Yan Jin, Ren Sun, Sumit K. Chanda, Kwok‐Yung Yuen - Nature 2021 cited by 211

  11. Observational study on wearable biosensors and machine learning-based remote monitoring of COVID-19 patients

    Authors: , , , , , , , , , , , , , , , , , , , - Scientific Reports 2021 cited by 82

  12. Sex Differences in Association Between Gut Microbiome and Essential Hypertension Based on Ambulatory Blood Pressure Monitoring

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hypertension 2023 cited by 63

  13. HBsAg Seroclearance in Chronic Hepatitis B in Asian Patients: Replicative Level and Risk of Hepatocellular Carcinoma

    Authors: , , , , , , , , - Gastroenterology 2008 cited by 409

  14. Bacillus Calmette-Guérin–induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - JCI Insight 2022 cited by 69

  15. SARS-CoV-2 infects human neural progenitor cells and brain organoids

    Authors: , , , , , , , , , , , , , , - Cell Research 2020 cited by 336

  16. Randomized Trial of Anticoagulation Strategies for Noncritically Ill Patients Hospitalized With COVID-19

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Valentı́n Fuster - Journal of the American College of Cardiology 2023 cited by 60

  17. Randomised clinical trial: rifaximin versus placebo for the treatment of functional dyspepsia

    Authors: , , , , , - Alimentary Pharmacology & Therapeutics 2017 cited by 140

  18. Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study

    Authors: , , , , , , , - The Lancet Infectious Diseases 2023 cited by 58

  19. The role of community-wide wearing of face mask for control of coronavirus disease 2019 (COVID-19) epidemic due to SARS-CoV-2

    Authors: , , , , , , , , , , - Journal of Infection 2020 cited by 928

  20. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2017 cited by 393

  21. Omicron sublineage recombinant XBB evades neutralising antibodies in recipients of BNT162b2 or CoronaVac vaccines

    Authors: , , , , , , , - The Lancet Microbe 2022 cited by 61

  22. SARS-CoV-2 exploits host DGAT and ADRP for efficient replication

    Authors: , , , , , , , , , , , , , , - Cell Discovery 2021 cited by 54

  23. Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Infectious Diseases 2010 cited by 426

  24. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study

    Authors: , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2021 cited by 251